ArticleHaematologica2026

Rituximab, dexamethasone, etoposide, ifosfamide and carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma: a retrospective multicentre clinical study.

Kudret Kama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.